Tag: NMPA

Pharma – Asia, S America, MENA, ROW Regulatory News – Aug 2025

September 3, 2025
Biopharma

ALGERIA Suspension and Withdrawal of HUP.P.PHARMA Products The National Agency for Pharmaceutical Products has announced the immediate suspension and withdrawal of all pharmaceutical products...

drug recalls, EDA, global pharma, GMP standards, NMPA, Pharma Regulatory News, pharmaceutical updates, Regulatory Compliance, TGA

Medical Devices-Asia and ROW Regulatory News-Oct. 2023

October 18, 2023
Medical Device

ASIA INDIA The Indian Regulatory Authority (CDSCO) has released List of medical devices testing laboratory (MDTL) for carry out test or evaluation of medical device on behalf of manufacturer...

ANVISA, Asia Regulatory News, Medical Devices, NMPA, Regulatory News, ROW Regulatory News, SaMD, SFDA

Registration of Drug-device Combination Products

October 8, 2021
Standards

NMPA Notice on Matters Concerning the Registration of Drug-device Combination Products With the view to strengthening registration management of drug-device combination products, in accordance with...

combinationproduct, drug, medicaldevice, NMPA, registrationofdrug, registrationondevice